Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910502 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Natalia Niedziela und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland. Hauptthemen laut MEDLINE: Biomarkers, Cholecalciferol, S100 Calcium Binding Protein beta Subunit, Multiple Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Permanent inflammatory demyelinating and neurodegenerative processes lead to neurological disability in patients with multiple sclerosis (MS). The anti-inflammatory properties of vitamin D3 (VitD) are well established, but its role in neurodegeneration is still uncertain. The usefulness of the serum concentration of VitD as a potential biomarker in evaluating brain injury in terms of recently known smoldering MS was under consideration. Methods: We assessed the concentrations of the parameters of brain injury (NF-H, GPAF, S100B, UCHL1) in the cerebrospinal fluid (CSF) of relapsing-remitting (RRMS, n = 123) and progressive MS (PMS, n = 88) patients in the group with normal levels of VitD (VitDn) and in the VitD deficiency group (VitDd). The levels of NF-H and UCHL1 were higher in the group of VitDd compared to VitDn. The higher serum levels of VitD were correlated with lower concentrations of GFAP, NF-H and S100B in the CSF of the whole group of MS patients and in women with MS as opposed to the levels of UCHL1. In men, there were noted negative correlations between the levels of serum VitD and GFAP and NF-H in CSF but not between VitD and S100B and UCHL1. The negative correlations were observed between VitD and the selected parameters of brain injury in MS patients, in women as well as in men. The concentrations of serum VitD together with selected parameters of brain injury in CSF seem to be promising biomarkers of neurodegeneration processes in smoldering MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland.
- Klaipeda University Hospital, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
- Department of Neurology, Medical University of Lodz, ul. Kopcińskiego 22, 90-153 Lodz, Poland.
- 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease ul, M.C. Sklodowskiej 9, 41-800 Zabrze, Poland.
- Department of Microbiology and Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. Jordana 19, 41-808 Zabrze, Poland.
ORCID-Profile: Natalia Niedziela, Mariusz Stasiołek, Zenon P Czuba, Martyna Lis, Monika Adamczyk-Sowa
Zitieren
APA
Niedziela, N., Nowak-Kiczmer, M., Malciene, L., Stasiołek, M., Niedziela, J. T., Czuba, Z. P., Lis, M., Sowa, A., & Adamczyk-Sowa, M. (2024). Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910502
Vancouver
Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiołek M, Niedziela JT, Czuba ZP, et al. Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910502
BibTeX
@article{Niedziela2024,
author = {Niedziela, Natalia and Nowak-Kiczmer, Maria and Malciene, Lina and Stasiołek, Mariusz and Niedziela, Jacek T and Czuba, Zenon P and Lis, Martyna and Sowa, Agata and Adamczyk-Sowa, Monika},
title = {Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910502}
}
EUVIMED